Cardiovascular morbidity and mortality among persons diagnosed with tuberculosis: A systematic review and meta-analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
10
12
2019
accepted:
23
06
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
15
9
2020
Statut:
epublish
Résumé
The emerging epidemiological evidence of increased cardiovascular disease (CVD) risk among persons diagnosed with tuberculosis (TB) has not been systematically reviewed to date. Our aim was to review the existing epidemiological evidence for elevated risk of CVD morbidity and mortality among persons diagnosed with TB compared to controls. EMBASE, MEDLINE, and Cochrane databases were searched (inception to January 2020) for terms related to "tuberculosis" and "cardiovascular diseases". Inclusion criteria: trial, cohort, or case-control study design; patient population included persons diagnosed with TB infection or disease; relative risk (RR) estimate and confidence interval reported for CVD morbidity or mortality compared to suitable controls. Exclusion criteria: no TB or CVD outcome definition; duplicate study; non-English abstract; non-human participants. Two reviewers screened studies, applied ROBINS-I tool to assess risk of bias, and extracted data independently. Random effects meta-analysis estimated a pooled RR of CVD morbidity and mortality for persons diagnosed with TB compared to controls. 6,042 articles were identified, 244 full texts were reviewed, and 16 were included, meta-analyzing subsets of 8 studies' RR estimates. We estimated a pooled RR of 1.51 (95% CI: 1.16-1.97) for major adverse cardiac events among those diagnosed with TB compared to non-TB controls (p = 0.0024). A 'serious' pooled risk of bias was found across studies with between-study heterogeneity (I2 = 75.3%). TB appears to be a marker for increased CVD risk; however, the literature is limited and is accompanied by serious risk of confounding bias and evidence of publication bias. Further retrospective and prospective studies are needed. Pending this evidence, best practice may be to consider persons diagnosed with TB at higher risk of CVD as a precautionary measure.
Identifiants
pubmed: 32649721
doi: 10.1371/journal.pone.0235821
pii: PONE-D-19-34201
pmc: PMC7351210
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0235821Subventions
Organisme : CIHR
ID : PJT-153213
Pays : Canada
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Can J Public Health. 2010 Sep-Oct;101(5):396-8
pubmed: 21214055
Lancet Infect Dis. 2019 Oct;19(10):1045-1047
pubmed: 31324515
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Circulation. 2012 Oct 16;126(16):2020-35
pubmed: 22923432
Respirology. 2017 Nov;22(8):1670-1676
pubmed: 28681508
Atherosclerosis. 2007 Jan;190(1):150-5
pubmed: 16510148
Clin Infect Dis. 2018 Mar 5;66(6):886-892
pubmed: 29069328
Arch Intern Med. 2007 Feb 26;167(4):335-42
pubmed: 17325294
Int J Tuberc Lung Dis. 2013 Jul;17(7):961-8
pubmed: 23743316
Am Heart J. 2019 Jun;212:23-35
pubmed: 30928825
Microbiol Mol Biol Rev. 2014 Sep;78(3):343-71
pubmed: 25184558
Lancet Infect Dis. 2019 Oct;19(10):1129-1137
pubmed: 31324519
Prim Care. 2014 Jun;41(2):371-97
pubmed: 24830613
Circulation. 2019 Jul 9;140(2):e98-e124
pubmed: 31154814
Int J Tuberc Lung Dis. 2016 Jan;20(1):43-8
pubmed: 26688527
Int J Tuberc Lung Dis. 2006 Aug;10(8):857-63
pubmed: 16898369
Eur Heart J. 2010 Mar;31(6):642-8
pubmed: 20176800
Stroke. 2010 Feb;41(2):244-9
pubmed: 20035070
Trop Dis Travel Med Vaccines. 2015;1:
pubmed: 26835156
Epidemiol Infect. 2017 May;145(7):1363-1367
pubmed: 28202093
Int J Tuberc Lung Dis. 2014 Jan;18(1):79-83
pubmed: 24365557
COPD. 2017 Apr;14(2):143-149
pubmed: 27880044
Medicine (Baltimore). 2016 Feb;95(8):e2883
pubmed: 26937925
N Engl J Med. 2019 Jan 10;380(2):171-176
pubmed: 30625066
Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1258-1268
pubmed: 30355404
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1253-1256
pubmed: 31753065
Clin Infect Dis. 2014 Jan;58(1):e1-34
pubmed: 24235263
Int J Mycobacteriol. 2018 Apr-Jun;7(2):143-147
pubmed: 29900890
Eur J Intern Med. 2014 Dec;25(10):936-40
pubmed: 25459212
Int J Tuberc Lung Dis. 2014 Dec;18(12):1473-8
pubmed: 25517814
J Int AIDS Soc. 2018 Jan;21(1):
pubmed: 29334197
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Int J Infect Dis. 2017 Mar;56:54-61
pubmed: 28027993
PLoS One. 2014 Jul 21;9(7):e98158
pubmed: 25048551
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
BMJ Open. 2016 Jul 12;6(7):e010247
pubmed: 27406637
Int J Infect Dis. 2015 Mar;32:138-46
pubmed: 25809770
Clin Epidemiol. 2014 Nov 13;6:405-21
pubmed: 25419160
Tanzan J Health Res. 2013 Apr;15(2):73-81
pubmed: 26591712
PLoS One. 2017 Apr 21;12(4):e0175925
pubmed: 28430796
BMC Public Health. 2010 May 19;10:259
pubmed: 20482835
Cureus. 2020 Mar 25;12(3):e7404
pubmed: 32337130
Int J Tuberc Lung Dis. 2018 Nov 1;22(11):1277-1285
pubmed: 30355406
PLoS One. 2015 Jul 14;10(7):e0133064
pubmed: 26172153